|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Mutiscale substrates based on hydrogel-incorporated silicon nanowires for protein patterning and microarray-based immunoassays显示文摘 | Sang Won Han Seulah Lee Juree Hong Eunji Jang Taeyoon Lee Won-Gun Koh | 2013 | Biosensors and Bioelectronics2013，，： | 2 |
| 2 | Missed synchronous gastric neoplasm with endoscopic submucosal dissection for gastric neoplasm: Experience in our hospital显示文摘 | Hyung Hun Kim Eun Ju Cho Eunji Noh Seok Reyol Choi Seun Ja Park Moo In Park Won Moon | 2012 | Digestive Endoscopy2012，，1： | 2 |
| 3 | Monte Carlo study of coherent diffuse photon transport in a homogeneous turbid medium: a degree-of-coherence based approach 显示文摘 | Seyoung M Dongyun K Eunji S | 2008 | Appl Opt2008，47，3： | 1 |
| 4 | Functional activation of macrophages, monocytes and splenic lymphocytes by polysaccharide fraction from Tricholoma matsutake显示文摘 | Se Eun Byeon Jaehwi Lee Eunji Lee Song Yi Lee Eock Kee Hong Young Eon Kim Jae Youl Cho | 2009 | Archives of Pharmacal Research2009，，11： | 1 |
| 5 | The use of a diatomite- kaolin composite coating to design the pore characteristics of a sin- tered diatomite membrane显示文摘 | Jang Hoon Ha Eunji Oh In Hyuck Song | 2014 | Ceram Int2014，40，1： | 1 |
| 6 | Tribological properties of copper alloy-based composites reinforced with tungsten carbide particles显示文摘 | HONGA Eunji KAPLINB Bradley YOUA Taehoon | 2011 | Wear2011，270，910： | 1 |
| 7 | New enzymatic time–temperature integrator (TTI) that uses laccase显示文摘 | Keehyuk Kim Eunji Kim Seung Ju Lee | 2012 | Journal of Food Engineering2012，，1： | 1 |
| 8 | Tribo?logical properties of copper alloy-based composites rein?forced with tungsten carbide particles显示文摘 | Eunji Hong Bradley Kaplin Taehoon You | 2011 | Wear2011，270，910： | 1 |
| 9 | Monte Carlo study of coherent diffuse photon transport in a homogeneous turbid medium:a degree-of-coherence based approach显示文摘 | SEYOUNG M DONGHYUN K EUNJI S | 2008 | Appl Opt2008，47，3： | 1 |
| 10 | Missed synchronous gastric neoplasm with endoscopic submucosal dissection for gastric neoplasm: Experience in our hospital显示文摘 | Hyung Hun Kim Eun Ju Cho Eunji Noh Seok Reyol Choi Seun Ja Park Moo In Park Won Moon | 2012 | Digestive Endoscopy2012，，1： | 1 |
| 11 | Tribolo- gical properties of copper alloy-based composites reinforced with tungsten carbide partieles显示文摘 | Eunji Hong Bradley Kaplin Taehoon You | 2011 | Wear2011，270，： | 1 |
| 12 | Fabrication of poly( ethylene glycol)-based hydrogels entrapping enzyme-immobilized silica nanoparticles 显示文摘 | Jang a Eunji Parka Saemi Parka Sangphil | 2010 | Polymers For Advanced Technologies2010，21，7： | 1 |
| 13 | Functional activation of macrophages,monocytes and splenic lymphocytes by polysaccharide fraction from Tricholomamatsutake显示文摘 | Byeon Se Eun Lee Jaehwi Lee Eunji | 2009 | Archives of Pharmacal Research2009，32，11： | 1 |
| 14 | Covalent organic framework nanomedicines:Biocompatibility for advanced nanocarriers and cancer theranostics applications显示文摘Nanomedicines for drug delivery and imaging-guided cancer therapy is a rapidly growing research area.The unique properties of nanomedicines have a massive potential in solving longstanding challenges of existing cancer drugs,such as poor localization at the tumor site,high drug doses and toxicity,recurrence,and poor immune response.However,inadequate biocompatibility restricts their potential in clinical translation.Therefore,advanced nanomaterials with high biocompat-ibility and enhanced therapeutic efficiency are highly desired to fast-track the clinical translation of nanomedicines.Intrinsic properties of nanoscale covalent organic frameworks(nCOFs),such as suitable size,modular pore geometry and porosity,and straightforward post-synthetic modification via simple organic transformations,make them incredibly attractive for future nanomedicines.The ability of COFs to disintegrate in a slightly acidic tumor microenvironment also gives them a competitive advantage in targeted delivery.This review summarizes recently published applications of COFs in drug delivery,photo-immuno therapy,sonodynamic therapy,photothermal therapy,chemotherapy,pyroptosis,and combination therapy.Herein we mainly focused on modifications of COFs to enhance their biocompatibility,efficacy and potential clinical translation.This review will provide the fundamental knowledge in designing biocompatible nCOFs-based nano-medicines and will help in the rapid development of cancer drug carriers and theranostics. | Nem Singh Jungryun Kim Jaewon Kim Kyungwoo Lee Zehra Zunbul Injun Lee Eunji Kim Sung-Gil Chi Jong Seung Kim | 2023 | Bioactive Materials2023，，3： | 1 |
| 15 | Development of Microfluidic Devices Incorporating Non-spherical Hydrogel Microparticles for Protein-based Bioassay 显示文摘 | Dongkil C Eunji J Jinwon P | 2008 | Microfluidics and Nanofluidies2008，5，5： | 1 |
| 16 | SVM-based Biological Named Entity Recognition u- sing Minimum Edit-Distance Feature Boosted by Virtual Exam- ples显示文摘 | Eunji Yi | 2004 | IJCNLP2004，，： | 1 |
| 17 | Fluorescent nanoswitch for monitoring specific pluripotency-related microRNAs of induced pluripotent stem cells: Development of polyethyleneimine- oligonucleotide hybridization probes显示文摘隔离高级(即 high-pluripotency ) 人的导致的 pluripotent 干细胞(hiPSCs ) 是为提高 hiPSC 人口或区别效率的纯净的一个明确的因素。能监视 microRNA (miRNA ) 的一个非侵略的成像系统表达式提供一个有用工具识别并且分析特定的房间人口。然而,由 miRNA 表示监视器 / 隔离 hiPSCs 上的以前的研究与 miRNA 成像 probe-nanocarriers 由于长期的孵化限制了 hiPSCs 区别系统。因此,我们集中了于没有影响 hiPSCs 的 pluripotency,监视高级 hiPSCs。我们减少了 nanoparticle transfection 时间,因为 hiPSCs 在孵化期间对在外部因素下面的自发的区别敏感。荧光灯 nanoswitch (在上与目标 miRNA ) ,它能被申请由荧光的成像或排序的特定的房间发信号,包含一根 miRNA 成像探针(miP ) 和 PEI 木钉 nanoparticle (miP-P ) 。因而,这 nanoswitch 能在 vitro 在 30 min 以内察觉到各种各样的内长的目标 miRNAs,并且没有影响 pluripotency,为不仅成像而且排序的 pluripotent hiPSCs 表明强壮的潜力。而且, miP-P-treated hiPSCs 区分很好进 endothelial 房间,显示那 miP-P 不改变 hiPSCs 的 pluripotency。我们想象那这个 miRNA 成像系统能为为改进实际应用程序识别并且排序高级 hiPSCs 是珍贵的。 | Seungmin Han Hye Young Son Byunghoon Kang Eunji Jang Jisun Ki Na Geum Lee Jongjin Park Moo-Kwang Shin Byeonggeol Mun Jeong-Ki Min Seungjoo Haam | 2017 | Nano Research2017，10，8： | 0 |
| 18 | Critical factors to inhibit water-splitting side reaction in carbon-based electrode materials for zinc metal anodes显示文摘Zinc metal anodes(ZMA)have high theoretical capacities(820 mAh g−1 and 5855 mAh cm−3)and redox potential(−0.76 V vs.standard hydrogen electrode),similar to the electrochemical voltage window of the hydrogen evolution reaction(HER)in a mild acidic electrolyte system,facilitating aqueous zinc batteries competitive in next-generation energy storage devices.However,the HER and byproduct formation effectuated by water-splitting deteriorate the electrochemical performance of ZMA,limiting their application.In this study,a key factor in promoting the HER in carbon-based electrode materials(CEMs),which can provide a larger active surface area and guide uniform zinc metal deposition,was investigated using a series of threedimensional structured templating carbon electrodes(3D-TCEs)with different local graphitic orderings,pore structures,and surface properties.The ultramicropores of CEMs are the determining critical factors in initiating HER and clogging active surfaces by Zn(OH)2 byproduct formation,through a systematic comparative study based on the 3D-TCE series samples.When the 3D-TCEs had a proper graphitic structure with few ultramicropores,they showed highly stable cycling performances over 2000 cycles with average Coulombic efficiencies of≥99%.These results suggest that a well-designed CEM can lead to high-performance ZMA in aqueous zinc batteries. | Dong Hyuk Kang Eunji Lee Beom Sik Youn Son Ha Jong Chan Hyun Juhee Yoon Dawon Jang Kyoung Sun Kim Hyungsub Kim Sang Moon Lee Sungho Lee Hyoung-Joon Jin Hyung-Kyu Lim Young Soo Yun | 2022 | Carbon Energy2022，4，6： | 0 |
| 19 | 8-(Tosylamino)quinoline inhibits macrophage-mediated inflammation by suppressing NF-KB signaling显示文摘 | Yongwoo JUNG Se Eun BYEON Dae Sung YOO Yong Gyu LEE Tao YU Yanyan YANG Ji Hye KIM Eunji KIM Deok JEONG Man Hee RHEE Eui Su CHOUNG Sungyoul HONG Jae Youl CliO | 2012 | Acta Pharmacologica Sinica2012，33，8： | 0 |
| 20 | Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer:Results from two large Korean cohorts显示文摘Objective:Benefits of adjuvant treatment in pT1 N1 gastric cancer(GC)remain controversial.Additionally,an effective biomarker for early GC is the need of the hour.The prognostic and predictive roles of single patient classifier(SPC)were validated in stageⅡ/ⅢGC.In this study,we aimed to elucidate the role of SPC as a biomarker for pT1 N1 GC.Methods:The present retrospective biomarker study(NCT03485105)enrolled patients treated for pT1 N1 GC between 1996 and 2012 from two large hospitals(the Y cohort and S cohort).For SPC,mRNA expression of four classifier genes(GZMB,WARS,SFRP4 and CDX1)were evaluated by real-time reverse transcription-polymerase chain reaction assay.The SPC was revised targeting pT1 stages and the prognosis was stratified as high-and lowrisk group by the expression of SFRP4,a representative epithelial-mesenchymal transition marker.Results:SPC was evaluated in 875 patients(n=391 and 484 in the Y and S cohorts,respectively).Among 864 patients whose SPC result was available,41(4.7%)patients experience GC recurrence.According to revised SPC,254(29.4%)patients were classified as high risk[123(31.5%)and 131(27.1%)in the Y and S cohorts,respectively].The high risk was related to frequent recurrence in both Y and S cohort(log-rank P=0.023,P<0.001,respectively),while there was no difference by GZMB and WARS expression.Multivariable analyses of the overall-cohort confirmed the high risk of revised SPC as a significant prognostic factor[hazard ratio(HR):4.402(2.293-8.449),P<0.001]of GC.A significant difference was not detected by SPC in the prognosis of patients in the presence and absence of adjuvant treatment(log-rank P=0.670).Conclusions:The present study revealed the revised SPC as a prognostic biomarker of pT1 N1 GC and suggested the use of the revised SPC for early-stage GC as like stageⅡ/Ⅲ. | Yoon Young Choi Eunji Jang Hyunki Kim Kyoung-Mee Kim Sung Hoon Noh Tae Sung Sohn Yong-Min Huh Ji Yeong An Jae-Ho Cheong | 2021 | Chinese Journal of Cancer Research2021，33，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员